JESSE BONE: Open Payments
NPI 1770039752 · MONTICELLO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 14 payments from 8 companies in 2025. Trend: 2023 $222 · 2024 $236 · 2025 $451
Food & beverage: $451
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $161 |
| Novo Nordisk Inc | 1 | $98 |
| Otsuka America Pharmaceutical, Inc. | 1 | $95 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Hologic Sales and Service, LLC | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: QULIPTA, Ozempic, REXULTI, VRAYLAR, AUSTEDO XR, APTIMA, MOUNJARO, CAPLYTA.
Industry payments across AR — which companies pay providers there.
